Modulation of interleukin-1β mediated inflammatory response in human astrocytes by flavonoids: Implications in neuroprotection

[1]  Jialin C. Zheng,et al.  Role of activated astrocytes in neuronal damage: Potential links to HIV-1-associated dementia , 2009, Neurotoxicity Research.

[2]  A. Basu,et al.  Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis , 2007, Glia.

[3]  G. Gutiérrez‐Venegas,et al.  Luteolin inhibits lipopolysaccharide actions on human gingival fibroblasts. , 2006, European journal of pharmacology.

[4]  N. Rothwell,et al.  Interleukin‐1‐induced neurotoxicity is mediated by glia and requires caspase activation and free radical release , 2006, Journal of neurochemistry.

[5]  J. Yodoi,et al.  Protective roles of redox-active protein thioredoxin-1 for severe acute pancreatitis. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[6]  S. Sharma,et al.  Quercetin protects C6 glial cells from oxidative stress induced by tertiary-butylhydroperoxide , 2006, Free radical research.

[7]  E. Major,et al.  Astrocyte differentiation selectively upregulates CCL2/monocyte chemoattractant protein‐1 in cultured human brain‐derived progenitor cells , 2006, Glia.

[8]  N. Rothwell,et al.  Interleukin-1 and neuronal injury , 2005, Nature Reviews Immunology.

[9]  C. Brosnan,et al.  IL‐1‐regulated responses in astrocytes: Relevance to injury and recovery , 2005, Glia.

[10]  S. Levison,et al.  Interleukin‐1: A master regulator of neuroinflammation , 2004, Journal of neuroscience research.

[11]  S. Levison,et al.  Pro‐regenerative properties of cytokine‐activated astrocytes , 2004, Journal of neurochemistry.

[12]  D. Begley,et al.  Corrigendum to Flavonoid permeability across an in situ model of the blood–brain barrier. Free Radic. Biol. Med. 36: 592–604; 2004. , 2004 .

[13]  D. Begley,et al.  Flavonoid permeability across an in situ model of the blood-brain barrier. , 2004, Free radical biology & medicine.

[14]  Hyun Pyo Kim,et al.  Anti-inflammatory plant flavonoids and cellular action mechanisms. , 2004, Journal of pharmacological sciences.

[15]  S. Levison,et al.  Astrocytic ceruloplasmin expression, which is induced by IL‐1β and by traumatic brain injury, increases in the absence of the IL‐1 type 1 receptor , 2003, Glia.

[16]  R. Ravid,et al.  Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli , 2003, Glia.

[17]  A. Ghorpade,et al.  HIV-1 and IL-1β regulate Fas ligand expression in human astrocytes through the NF-κB pathway , 2003, Journal of Neuroimmunology.

[18]  R. Swanson,et al.  Astrocytes and Brain Injury , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  B. Havsteen,et al.  The biochemistry and medical significance of the flavonoids. , 2002, Pharmacology & therapeutics.

[20]  Jonathan R. Enterline,et al.  Transforming growth factor β1 prevents IL‐1β–induced microglial activation, whereas TNFα‐ and IL‐6–stimulated activation are not antagonized , 2002 .

[21]  Jean-Pierre Julien,et al.  Ceruloplasmin Regulates Iron Levels in the CNS and Prevents Free Radical Injury , 2002, The Journal of Neuroscience.

[22]  E. Sen,et al.  Genetic Analysis of cis Regulatory Elements within the 5′ Region of the Human Papillomavirus Type 31 Upstream Regulatory Region during Different Stages of the Viral Life Cycle , 2002, Journal of Virology.

[23]  J. Ross,et al.  Dietary flavonoids: bioavailability, metabolic effects, and safety. , 2002, Annual review of nutrition.

[24]  A. R. Little,et al.  Astrogliosis in the adult and developing CNS: is there a role for proinflammatory cytokines? , 2001, Neurotoxicology.

[25]  Y. Pang,et al.  Analysis of genes differentially expressed in astrocytes stimulated with lipopolysaccharide using cDNA arrays , 2001, Brain Research.

[26]  Chulhee Choi,et al.  CXC Chemokine Receptor 4 Expression and Function in Human Astroglioma Cells1 , 2001, The Journal of Immunology.

[27]  A. Yu,et al.  Quercetin inhibits c‐fos, heat shock protein, and glial fibrillary acidic protein expression in injured astrocytes , 2000, Journal of neuroscience research.

[28]  J. Hirrlinger,et al.  Glutathione metabolism in brain , 2000 .

[29]  L. Murray,et al.  Association of interleukin‐1 gene polymorphisms with Alzheimer's disease , 2000, Annals of neurology.

[30]  Clive N Svendsen,et al.  Leukocyte Infiltration, Neuronal Degeneration, and Neurite Outgrowth after Ablation of Scar-Forming, Reactive Astrocytes in Adult Transgenic Mice , 1999, Neuron.

[31]  M. Aschner,et al.  Immune and inflammatory responses in the CNS: modulation by astrocytes. , 1998, Toxicology letters.

[32]  S. K. Malhotra,et al.  Reactive astrocytes: cellular and molecular cues to biological function , 1997, Trends in Neurosciences.

[33]  John X. Wilson,et al.  Antioxidant defense of the brain: a role for astrocytes. , 1997, Canadian journal of physiology and pharmacology.

[34]  E. Major,et al.  Recombinant human interleukin 1β induces production of prostaglandins in primary human fetal astrocytes and immortalized human fetal astrocyte cultures , 1996, Journal of Neuroimmunology.

[35]  A. Messing,et al.  Conditional Ablation of Cerebellar Astrocytes in Postnatal Transgenic Mice , 1996, The Journal of Neuroscience.

[36]  H. R. Zielke,et al.  Exogenous Glutamate Concentration Regulates the Metabolic Fate of Glutamate in Astrocytes , 1996, Journal of neurochemistry.

[37]  R. Carlson,et al.  Tyrosine Kinase Activity Is Essential for Interleukin‐1β‐Stimulated Production of Interleukin‐6 in U373 Human Astrocytoma Cells , 1995, Journal of neurochemistry.

[38]  L. Eng,et al.  GFAP and Astrogliosis , 1994, Brain pathology.

[39]  P. Baeuerle,et al.  [14] Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-κB , 1994 .

[40]  R. Gebhardt,et al.  Glycogen in astrocytes: possible function as lactate supply for neighboring cells , 1993, Brain Research.

[41]  L. Mucke,et al.  Astrocytes in infectious and immune‐mediated diseases of the central nervous system , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  J. Lile,et al.  GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.

[43]  A. Carè,et al.  Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. , 1992, Journal of immunology.

[44]  E. Benveniste,et al.  Induction and regulation of interleukin-6 gene expression in rat astrocytes , 1990, Journal of Neuroimmunology.

[45]  Reier Pj,et al.  The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair. , 1988 .